TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/30/24 16:16 | 8/28/24 | INBX | Inhibrx Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Manhard Kimberly | CA | D | P | 140 | 13.98 | 0 | 10 | New | 10 | I | |||||||||||||||
4/17/23 17:26 | 4/13/23 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Manhard Kimberly | CA | O | EVP,Drug | M.d | 0 | 0.00 | 0 | 6 | 26 | 28 | D | ||||||||||||||
1/17/23 17:34 | 1/13/23 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Manhard Kimberly | CA | DO | EVP,Drug | M.d | 0 | 0.00 | 0 | 6 | 32 | 24 | D | ||||||||||||||
10/17/22 16:36 | 10/13/22 | HRTX | Heron Therapeutics, Inc. /de/ | DE | Health | Drug | Pharmaceutical Preparations | Manhard Kimberly | CA | DO | EVP,Drug | M.d | 0 | 0.00 | 0 | 6 | 46 | 18 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |